AstraZeneca and Oracle Launch AI Partnership to Improve Clinical Trials and Patient Care

AstraZeneca (NYSE:AZN) has entered into a partnership with Oracle (NYSE:ORCL) to investigate how artificial intelligence and cloud-based technology can improve clinical research and healthcare processes across several international markets. The agreement will combine AstraZeneca’s pharmaceutical research activities with Oracle’s AI, cloud computing and data management systems, focusing on practical applications within clinical development and patient care.